Canada study: Removing fallopian tubes during routine surgery may sharply reduce ovarian cancer risk
Latest news on WhatsApp أجدد الأخبار على واتسابA large Canadian population-based study suggests that opportunistic removal of the fallopian tubes during routine gynecologic surgery is associated with a substantial reduction in the risk of serous ovarian cancer, the most common and deadliest ovarian cancer subtype.
Known as opportunistic salpingectomy, the approach involves removing the fallopian tubes when a patient is already undergoing procedures such as hysterectomy for benign reasons or permanent contraception, while leaving the ovaries in place. The strategy is rooted in growing evidence that many high-grade serous cancers may originate in the fallopian tubes rather than the ovaries.
In the JAMA Network Open study, researchers analyzed health and cancer data from more than 85,000 people in British Columbia who underwent gynecologic surgery between 2008 and 2020. They reported that those who had opportunistic salpingectomy had markedly lower rates of serous ovarian cancer, consistent with roughly a 78 percent relative reduction compared with similar surgeries without tube removal.
The findings are significant because ovarian cancer remains difficult to detect early and there is no reliable population-wide screening test, placing a premium on prevention and informed medical decision-making.
Authors and institutional summaries emphasized that the evidence comes from real-world observational data, not a randomized trial, and that the procedure is not intended as a standalone surgery solely for prevention. Instead, they frame it as an option to discuss when a patient is already having gynecologic surgery, taking into account individual risk factors, fertility plans, benefits, and potential harms.
